Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
Combined telomerase inhibitor and gemcitabine for the treatment of cancer

No-Receipt date 2018-04705 - 18/12/2018
No-Filing date 20180403792 - 18/12/2018
No-Granting date 3098289 - 24/01/2019
No-EPO application date 14198829.5 - 30/10/2007
No-EPO granting date 2898887 - 26/09/2018
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 1/2019 - 04/04/2019
Expiration date 31/10/2027
Kind of title Validation of European Patent
Legal status VALID
Priorities US855583 P30/10/2006/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/70

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
952942 GERON CORPORATION 149 COMMONWEALTH DRIVEMENLO PARK, CA 94025 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
2382700 GO, NING
2382701 TRESSLER, ROBERT J.

Representatives
CodeFirstnameSurnameAddressTownZip
3614AIKATERINISIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"PATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History

Title Instruments

Payments history 18 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015